Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Spilling the beans! LONGS are still hopeful.
Or perhaps SEEKING Alpha has a greater point on inside buying?
added a few shares @.41 Perhaps will move on joint venture in relative near term.
Perhaps will move up here. What is the driver on this pre volume?
Perhaps will move up here. What is the driver on this pre volume?
Perhaps will move up here. What is the driver on this pre volume.
Perhaps was sooner then I thought. Will take it.
no longer perhaps. Nice.
Certainly by this next quarter their should be some follow up
information regarding SUNRISE data as related to their observations
of control arm out performance and bavi performing as expected.
Otherwise what would be the point of even making the statement unless their was an intention to provide future data results to shareholders?
If control control arm out performed historical norms and bavi performed as expected is all we have with no further follow up statements to explain this, then I have an issue with SK.
When you make these statements at the CC to the share holders you
(in my opinion) owe them an explanation as the data analysis is completed.
added some more shares today. Perhaps partner arrangement in future possible before phase 3 results??
Perhaps by next QTR will move to a $1 on PPS negating a RS
Perhaps a subset of good data will emerge from SUNRISE??
Valuation: Debt/expense vs Revenue/income etc.
P/E ratio EPS etc.
An analyst placing a value on a company looks at the company's management, the composition of its capital structure, the prospect of future earnings and market value of assets. Not there yet.
Hemorrhaging money still.
What's going on?
added more shares on the news this afternoon will see what develops
There are others not just PP. BTW
GEO
Here in lies the issue at least up to this point as you mentioned. No human trails providing statistical significance yet. Remove AVID and we set at .05-10 cents or less after Sunrise results. Avid is the straw that does not break the camels back.
insert-text-here
May he be at peace. EOM
ENDO If I may interject I once owned 175,000 shares but I would not have considered myself a true tong. Now I just trade shares until something develops that would tip me back into a hold position.
Hornet
This and other reasons is why I am completely out. Just trading it from time to time. Better to cast a wide net on several other speculative Bios then to invest all your money into this. Not being negative just stating the obvious. Dilution and RR seem to be the modus operandi for the BOD. Their salaries are all funded by us and can only be perpetuated by this process. Hope I am wrong for all the LONGS here. Will AVID keep the boat afloat and hold the dilution down some and can BAVI break out. Who knows??
Yes just trading this now on ups and downs. The carrots help for this.
RM I made a decent profit. Good enough for me.
and sold at nice profit
Good shape on share average.
Yes amateur hour is correct. Brilliant.
ok bought a bunch more @41 lets get the ball rolling
Good ole TCLN remember when they had around 18 employees.
Good observation
What is bringing the volume?
offering up millions more common. Dilution.
Lower burn rate and higher evaluation should move the needle some.
However there are a lot of longs still waiting on that golden parachute. Sill possible? Until then we wait and see.
Casting a wider net in spec bios has helped thank you EBIO. PPHM next?
Improved valuations should improve PPS threshold.
With a Short % of Float of around 4.70%. PPHM just needs valuation and some positive comprehensive news drivers for this little BIO
to gain some momentum for longs. The float is low because their is the specter of this developing.
Any post analysis on SUNRISE patients for any sub groups promising. Or not available yet?
Well stated
With map above for directions we have this below:
Driving directions to Peregrine Pharmaceuticals, Inc. and product information about TALCEPTRX is provided. TALCEPTRX is a product created by Peregrine Pharmaceuticals, Inc. in 14282 Franklin Avenue , Tustin, CA, 92780. The TALCEPTRX is a product related to Pharmaceutical preparations, namely, antibodies for the treatment and diagnosis of cancer, infectious diseases and diseases and disorders in which phosphatidylserine (ps) is a marker. The TALCEPTRX product has not yet been made publicly available yet in the United States. The TALCEPTRX is in the category of Pharmaceutical Products .
Get in contact with the owner, Peregrine Pharmaceuticals, Inc. of this TALCEPTRX, or visit them at their place of business in the map. Write a review about the product with this TALCEPTRX.
Or, contact the owner Peregrine Pharmaceuticals, Inc. of the TALCEPTRX trademark by filing a request to communicate with the Legal Correspondent for licensing, use, and/or questions related to TALCEPTRX. The correspondent of the TALCEPTRX is ILENE B. TANNEN of JONES DAY, 222 E 41ST ST FL 2, NEW YORK NY 10017-6727 .
link https://trademarks.justia.com/867/70/talceptrx-86770397.html
No just one of those simple over-sites when coping, pasting and typing. glad we have eyes over seeing mistakes on board
I know that has been brought to my attention. thanks
I feel ya GALE we now how phase 111 can go.
NCCN
Planned studies include bavituximab in combination with pembrolizumab (AZN) in hepatocellular carcinoma,and durvalumab (MERCK) in NSCLC. Good